Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 9/20 | 0.43 |
| ▸ | KDR | P35968 | 4/20 | 0.43 |
| ▸ | EGFR | P00533 | 7/20 | 0.41 |
| ▸ | ERBB2 | P04626 | 4/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.36 |
| ▸ | APP | P05067 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6613788 | 0.91 | SRC (0.47) | SRCKDREGFRSLC6A2SLC6A4 | |
| SCHEMBL6618997 | 0.90 | EGFR (0.49) | SRCKDREGFRERBB2KCNH2 | |
| SCHEMBL6613963 | 0.88 | EGFR (0.47) | SRCKDREGFRERBB2SLC6A2 | |
| SCHEMBL6613784 | 0.88 | SRC (0.43) | SRCKDREGFRSLC6A2SLC6A4 | |
| SCHEMBL6614596 | 0.88 | SRC (0.42) | SRCKDREGFRERBB2SLC6A2 | |
| SCHEMBL6646965 | 0.87 | SRC (0.46) | SRCKDREGFRERBB2KCNH2 | |
| SCHEMBL6617287 | 0.86 | SRC (0.46) | SRCKDREGFRERBB2SLC6A2 | |
| SCHEMBL6612571 | 0.85 | SRC (0.44) | SRCKDREGFRERBB2KCNH2 | |
| SCHEMBL6617924 | 0.81 | EGFR (0.46) | SRCKDREGFRERBB2KCNH2 | |
| SCHEMBL6620697 | 0.80 | SLC6A2 (0.42) | SRCKDREGFRERBB2KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1444211-A2 | QUINAZOLINE DERIVATIVES AS ANTITUMOR AGENTS | AstraZeneca AB (SE) | 2004-08-11 | — | — | EP | disclosed |
| WO-2003040109-A2 | QUINAZOLINE DERIVATIVES AS ANTITUMOR AGENTS | ASTRAZENECA AB (SE) | 2003-05-15 | — | — | WO | disclosed |